Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa in depression with high inflammation
NCT02513485Phase 4Completed
- Sponsor
- Emory University
- Start
- Oct 2015
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in major depressive disorder (MDD), sponsored by Emory University. Started Oct 2015; status: completed.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02513485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513485.